E-LIB Suche - Ergebnisse für: Lacabaratz, C.

1

Immune response to pertussis vaccine in COPD patients:

Feredj, E. ; Wiedemann, A. ; Krief, C....
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

2

A Randomized Placebo-Controlled Efficacy Study of a Prime B..:

Lévy, Y. ; Lacabaratz, C. ; Lhomme, E....
Journal of Virology. 95 (2021) 9 - p. , 2021

Link: https://doi.org/10.1128/..

3

HIV infection en route to endogenization: two cases:

Colson, P. ; Ravaux, I. ; Tamalet, C....
Clinical Microbiology and Infection. 20 (2014) 12 - p. 1280-1288 , 2014

Link: https://doi.org/10.1111/..

4

HIV "Elite Controllers" Are Characterized by a High Frequen..:

Carriere, M. ; Lacabaratz, C. ; Kok, A....
Journal of Infectious Diseases. 209 (2013) 9 - p. 1321-1330 , 2013

Link: https://doi.org/10.1093/..

5

Vaccination with dendritic cells loaded with HIV-1 lipopept..:

Levy, Y ; Thiébaut, R ; Montes, M...
Retrovirology. 9 (2012) S2 - p. , 2012

Link: https://doi.org/10.1186/..

6

IL-7 abrogates memory T regulatory cell functions by modula..:

Younas, M ; Hue, S ; Surenaud, M...
Retrovirology. 9 (2012) S2 - p. , 2012

Link: https://doi.org/10.1186/..

7

Immune response to pertussis vaccine in COPD patients:

Feredj, E ; Wiedemann, A ; Krief, C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356756/. , 2023

Link: http://www.ncbi.nlm.nih...

8

NK cell subset redistribution and antibody dependent activa..:

Wagstaffe, HR ; Anzala, O ; Kibuuka, H...
Vaccines. , 2022

Link: http://hdl.handle.net/10..

9

A randomized placebo-controlled efficacy study of a prime b..:

Levy, Y ; Lacabaratz, C ; Lhomme, Edouard...
info:eu-repo/semantics/altIdentifier/doi/10.1128/jvi.02165-20. , 2021

Link: https://hal.archives-ouv..

10

A randomized placebo-controlled efficacy study of a prime b..:

Levy, Y ; Lacabaratz, C ; Lhomme, Edouard...
info:eu-repo/semantics/altIdentifier/doi/10.1128/jvi.02165-20. , 2021

Link: https://hal.science/hal-..

11

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV..:

Barry, H ; Mutua, G ; Kibuuka, H...
doi:10.1371/journal.pmed.1003813. , 2021

Link: https://doi.org/10.1371/..

12

Durable natural killer cell responses after heterologous tw..:

WAGSTAFFE, H. R ; SUSANNINI, G ; THIEBAUT, Rodolphe...
2059-0105 (Electronic) 2059-0105 (Linking). , 2021

Link: https://oskar-bordeaux.f..

13

A randomized placebo-controlled efficacy study of a prime b..:

Levy, Y ; Lacabaratz, C ; Lhomme, Edouard...
info:eu-repo/semantics/altIdentifier/doi/10.1128/jvi.02165-20. , 2021

Link: https://hal.science/hal-..

14

A randomized placebo-controlled efficacy study of a prime b..:

LEVY, Y ; LACABARATZ, C ; LHOMME, Edouard...
0022-538x. , 2021

Link: https://oskar-bordeaux.f..

15

Safety and immunogenicity of a two-dose heterologous Ad26.Z..:

POLLARD, A. J ; LAUNAY, O ; LELIEVRE, J. D...
1474-4457 (Electronic) 1473-3099 (Linking). , 2020

Link: https://oskar-bordeaux.f..